FIRST QUARTER SALES AND DIABETES PRODUCT EXPANSION SHOW STRONG POTENTIAL FOR 2018
“The Company is also pleased to report that the newly launched Hutang-1 diabetes product has now reached over 80,000 consumers, including over 24,000 diabetes or pre-diabetes patients and showed promising conversion to sales. This commercial roll-out is being conducted with four dedicated retail stores in Xiamen and a direct community outreach program.” From Eagle Health sales report today.
- Forums
- ASX - By Stock
- EVE has legs
FIRST QUARTER SALES AND DIABETES PRODUCT EXPANSION SHOW STRONG...
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add EVE (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $5.274M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
EVE (ASX) Chart |
Day chart unavailable